Pharma News, 2023

Janssen Pharmaceuticals, a division of Johnson & Johnson, received European Commission marketing authorization for its prostate cancer drug Akeega (niraparib and abiraterone acetate), the first...

IN8bio Inc. on Tuesday said INB-400 and INB-410 received the U.S. Food and Drug Administration's orphan drug designation for a range of malignant glioma treatments, including newly diagnosed gliobl...

The results indicated TTHX1114 activated dose-dependent response in corneal oedema resolution and improved BCVA after surgery in all the patients.

AstraZeneca and Ionis Pharmaceuticals have reported that eplontersen met all co-primary endpoints and secondary endpoints in the Phase III NEURO-TTRansform trial in hereditary transthyretin-mediate...

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the U.S. Fo...

Amphastar Pharmaceuticals will buy Baqsimi from Eli Lilly and Co in a deal worth up to $1.08 billion as it aims to boost its portfolio of low blood sugar drugs, the two companies said on Monday. ...

Xortx Therapeutics has received Orphan Drug designation for its Xorlo (oxypurinol) drug to treat autosomal dominant polycystic kidney disease, the most common form of polycystic kidney disease. ...

Based on years of research, the gene-therapy treatment for glaucoma developed with a biotech company can help prevent vision lo
ss.

A flurry of deals suggests that drug firms favour buying their way out of trouble.

Dr. Reddy's Laboratories Ltd. , along with its subsidiaries together referred to as "Dr. Reddy's", today announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent gen...

Researchers from the University of Michigan have found that an extra copy of a gene in Down syndrome patients causes improper development of neurons in mice.

More research needed to determine if sleep medications prevent, delay Alzheimer’s.